Brad is a payer strategy and market access consulting executive with significant consulting/agency and pharmaceutical industry experience. Brad has deep expertise across multiple therapeutic areas including biologics, oncology, and specialty products, as well as a strong understanding of current and evolving healthcare delivery models including Commercial Managed Care, Pharmacy Benefit Managers (PBMs), Government (i.e. Medicare Part D, Medicaid, VAs/Tricare), Accountable Care Organizations (ACOs), Health Exchanges, Long Term Care/Home Health, and Employers..
Prior to joining RxC International, Brad founded MediMedia Managed Markets, LLC, which he led for 16 years before a successful divestiture of the company (now owned by ICON plc). Brad successfully leveraged his extensive strategy consulting experience at Charles River Associates where he served as a payer strategist and at NucleusX where he served as Global Head of Market Access and HEOR. Brad also gained significant biopharma industry experience early in his career at Marion Labs and Ortho Biotech/Johnson & Johnson.
Throughout his career, Brad has been instrumental to the success of a number of blockbuster drugs and biopharmaceutical/specialty products while ensuring the highest level of client focus and satisfaction. "I’m very excited about joining RxC International to add market access to their expertise and provide clients with a more complete suite of critically important services. Following product approval, market access and reimbursement often are the most important determinants of product uptake, revenue, and life cycle success,” said Kozar.
Brad serves on boards for several nonprofit organizations, has served on the Industry Advisory Board of the Academy of Managed Care Pharmacy (AMCP), and has frequently been a speaker at conferences on managed care and market access. He has moderated more than 800 customer policy, research, and advisory board meetings as well as served as a panel moderator and trainer.